Between 2013 and 2023, the R&D budget for health and medical sciences in Belgium has seen a general decline. Notable fluctuations include significant year-on-year growth in 2016 by 27.4% and a decline from 2014 onwards with a notable negative CAGR of -0.96% over the last five years to 2023, where it stood at 1.37 units of total government support.
Future forecasts indicate a continued slight decline with a projected CAGR of -0.73% through 2028, culminating in an R&D budget of 1.31 units. This represents a 3.62% total decrease over the next five years.
Future trends to watch for:
- Potential shifts in government priorities or budgets for healthcare and medical R&D.
- Impact of global health crises or innovations necessitating increased R&D spending.
- European Union strategic plans and funding changes affecting member states' budgets.
